Experience
Otsuka Pharmaceutical Co.
Teva Pharmaceuticals USA, Inc.
Represented Otsuka in Hatch-Waxman patent infringement litigations against multiple companies seeking to market generic versions of Otsuka’s Abilify® Oral Solution. All matters settled on confidential terms favorable to Otsuka.
Otsuka Pharmaceutical Co. v. Teva Pharmaceuticals USA, Inc., 3:08-cv-01583, D.N.J., Judges Cooper, Goodman, Hughes
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
District court ruling maintains patent and regulatory protection of Otsuka’s Abilify®
Otsuka Pharmaceutical Co., Ltd.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
Abbott Laboratories
Otsuka Pharmaceutical Co., Ltd. v. Apotex Corp.
Otsuka Pharmaceutical Co., Ltd.
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
Eli Lilly and Company
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Pronova Biopharma Norge AS
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.